LSE - Delayed Quote GBp
Aptamer Group PLC (APTA.L)
0.3850
0.0000
(0.00%)
At close: May 2 at 3:58:01 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Bunka (David Harry John) -- | Bought | Dec 19, 2024 | 19,842,070 |
| Chari (s) -- | Increase | May 28, 2024 | 28,224,561 |
| Crux Asset Management Limited -- | Annual Return | Oct 3, 2024 | 100,000,000 |
| Dowgate Group Ltd. -- | Decrease | Feb 20, 2025 | 98,751,049 |
| Fielding (Dean Andrew) -- | Annual Return | Oct 21, 2024 | 1,727,400 |
| Hargreaves (Adam) -- | Bought | Dec 9, 2024 | 137,045,972 |
| Hull (Stephen) -- | Annual Return | Oct 21, 2024 | 2,436,400 |
| Slater (Nicholas) -- | Annual Return | Oct 3, 2024 | 122,500,000 |
| Sykes (Tim) -- | Bought | Feb 3, 2025 | 8,671,063 |
| Tolley (Arron Craig) -- | Bought | Dec 9, 2024 | 23,240,959 |
Related Tickers
PYC.L Physiomics Plc
0.4200
-1.18%
CIZ.L Cizzle Biotechnology Holdings Plc
1.5500
0.00%
GENF.L Genflow Biosciences plc
0.8750
-14.63%
BSFA.L BSF Enterprise Plc
3.1250
-5.30%
NFX.L Nuformix plc
0.1250
-5.66%
OXB.L Oxford Biomedica plc
295.00
0.00%
ACTU Actuate Therapeutics, Inc. Common stock
9.89
-6.08%
ENSC Ensysce Biosciences, Inc.
2.4700
-3.89%
CRSP CRISPR Therapeutics AG
37.62
-1.65%